Direct inhibitions of the activities of steroidogenic cytochrome P-450 mono-oxygenase systems by anticonvulsants

Journal of Steroid Biochemistry and Molecular Biology

Volumn 60, Issue 1-2, 1997, Pages 77-85

  Ohnishi, Taira ^a   Ichikawa, Yoshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENODOXIN; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; CYTOCHROME P450; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; HYDANTOIN; ISOENZYME; PHENYTOIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; UNSPECIFIC MONOOXYGENASE; VALPROIC ACID;

ADRENAL CORTEX CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MICROSOME; MITOCHONDRION; NONHUMAN; PLACENTA; STEROIDOGENESIS; TESTIS;

ADRENODOXIN; ANDROSTENEDIONE; ANIMALS; ANTICONVULSANTS; AROMATASE; CATTLE; CHOLESTEROL; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CYTOCHROME P-450 ENZYME SYSTEM; DESOXYCORTICOSTERONE; ESTROGENS; ESTRONE; FEMALE; FERREDOXIN-NADP REDUCTASE; HUMANS; MALE; MICROSOMES; NADH, NADPH OXIDOREDUCTASES; NADPH-FERRIHEMOPROTEIN REDUCTASE; PLACENTA; PREGNANCY; PREGNENOLONE; PROGESTERONE; RATS; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE; STEROIDS; TESTIS;

EID: 0030976477     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00166-5     Document Type: Article

References (30)

1. Luhdorf K., Christiansen P., Hansen J. M. and Lund N.: The influence of phenytoin and carbamazepin on endocrine function, preliminary results. In Epilepsy, the 8th International Symposium (Edited by Henry J. K.). Raven Press, New York (1977) pp. 209-213.
2. Dana-Haeri J. and Oxley J.: Reduction of free testosterone by antiepileptic drugs. BMJ 284 (1982) 85-86.
3. Toone B. K., Wheeler M., Nanjee M., Fenwick P. and Grant R.: Sex hormones, sexual activity and plasma anticonvulsant levels in male epileptics. J. Neurol. Neurosurg. Psychiatr. 46 (1983) 824-826.
4. Wheeler M. J., Toone B. K., Dannatt A., Fenwick P. B. C. Brown S.: Metabolic clearance rate of testosterone in male epileptic patients on anti-convulsant therapy. J. Endocr. 129 (1991) 465-468.
5. Kühn-Velten W. N., Herzog A. G. and Müller M. R.: Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis. Eur. J. Pharmacol. 181 (1990) 151-155.
6. Janz D. and Schmidt D.: Anti-epileptic drugs and failure of oral contraceptives. Lancet I (1974) 1113.
7. Mattson R. H., Cramer J. A., Darney P. D. and Naftolin F.: Use of oral contraceptives by women with epilepsy. JAMA 256 (1984) 238-240.
8. Harrington M. G. and Hodkinson H. M.: Anticonvulsant drugs and bone disease in the elderly. J. Roy. Soc. Med. 80 (1987) 425-427.
9. French J.: The long-term therapeutic management of epilepsy. Ann. Intern. Med. 120 (1994) 411-422.
10. Schmid F.: Osteopathien bei antiepileptischer Dauerbehandlung. Fortschr. Med. 58 (1967) 381-382.
11. Kruse R.: Osteopathien bei antiepileptischer Langzeittherapie. Monatsschr. Kinderheilkd. 116 (1968) 378-381.
12. Hahn T. J., Hendin B. A., Scharp C. R. and Haddad J. G. Jr: Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N. Engl. J. Med. 287 (1972) 900-904.
13. Jubiz W., Haussler M. R., McCain T. A. and Tolman K. G.: Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs. J. Clin. Endocr. Metab. 44 (1977) 617-621.
14. Weinstein R. S., Bryce G. F., Sappington L. J., King D. W. Gallagher B. B.: Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J. Clin. Endocr. Metab. 58 (1984) 1003-1009.
15. Horowitz M. C.: Cytokines and estrogen in bone, anti-osteoporotic effects. Science 260 (1993) 626-627.
16. Perucca E., Hedges A., Makki K. A., Ruprah M., Wilson J. F. Richens A.: A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Br. J. Clin. Pharmacol. 18 (1984) 401-410.
17. 3-activating cytochrome P-450-linked mono-oxygenase systems. J. Steroid Biochem. Molec. Biol. 39 (1991) 479-485.
18. Hiwatashi A. and Ichikawa Y.: Physicochemical properties of reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from bovine adrenocortical microsomes. Biochim. Biophys. Acta 580 (1979) 44-63.
19. Mitoma C., Posner H. S., Reitz H. C. and Udenfriend S.: Enzymatic hydroxylation of aromatic compounds. Arch. Biochem. Biophys. 61 (1956) 431-441.
20. Hiwatashi A., Ichikawa Y., Maruya N., Yamano T. and Aki K.: Properties of crystalline reduced nicotinamide adenine dinucleotide phosphate-adrenodoxin reductase from bovine adrenocortical mitochondria. I. Physicochemical properties of holo- and apo-NADPH-adrenodoxin reductases and interaction between non-heme iron proteins and reductase. Biochemistry 15 (1976) 3082-3090.
21. 11β-reconstituted system from bovine adrenocortical mitochondria. J. Biochem. 100 (1986) 1065-1076.
22. Katagiri M., Takemori S., Itagaki E. and Suhara K.: Purification of adrenal cytochrome P-450 (cholesterol desmolase and steroid 11β- and 18-hydroxylase). Meth. Enzymol. 52 (1978) 124-132.
23. 11β-mediated reactions by imidazole derivatives and mineralocorticoid analogs. J. Steroid Biochem. 1988 (1988) 803-808.
24. Suhara K., Fujimura Y., Shiroo M. and Katagiri M.: Multiple catalytic properties of the purified and reconstituted cytochrome P-450 (P450sccII) system of pig testis microsomes. J. Biol. Chem. 259 (1984) 8729-8736.
25. Thompson E. A. Jr and Sitteri P. K.: Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J. Biol. Chem. 249 (1974) 5364-5372.
26. Strobel H. W. and Dignam J. D.: Purification and properties of NADPH-cytochrome P-450 reductase. Meth. Enzymol. 52 (1978) 89-96.
27. Laughton C. A., Zvelebil M. J. and Neidle S.: A detailed molecular model for human aromatase. J Steroid Biochem. Molec. Biol. 44 (1993) 399-407.
28. Zhou D., Cam L. L., Laughton C. L., Korzekwa K. R. and Chen S.: Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P-450. J. Biol. Chem. 269 (1994) 19501-19508.
29. Kurokohchi K., Nishioka M. and Ichikawa Y.: Inhibition mechanism of reconstituted cytochrome P-450scc-linked monooxygenase system by antimycotic reagents and other inhibitors. J. Steroid Biochem. Molec. Biol. 42 (1992) 287-292.
30. Vanden Bossche H., Willemsens G., Cools W. and Bellens D.: Effects of etomidate on steroid biosynthesis in subcellular fractions of bovine adrenals. Biochem. Pharmacol. 33 (1984) 3861-3868.